Skip to main content
. 2008 Sep 3;105(36):13656–13661. doi: 10.1073/pnas.0803522105

Fig. 1.

Fig. 1.

BRET measurements of cAMP levels in living cells to monitor dopamine D2L receptor activation. (A and B) Variations of cAMP levels in HEK293 cells stably expressing the EPAC biosensor and D2LR. (A) Kinetics of cAMP variations after treatment of the cells at time 0 with forskolin (25 μM) in the absence (▵) or presence (■) of quinpirole 1 μM as indicated and the emission ratios (Rluc/YFP) were measured. Cells incubated in PBS (○) were used as a negative control. (B) Dose-response curve of quinpirole for inhibiting forskolin-stimulated cAMP accumulation in HEK cells. cAMP production was normalized to the percentage of forskolin-stimulated cAMP accumulation (set at 100%).